Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
about
Current and emerging biologics for ulcerative colitis.Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritisCurrent status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update.Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease.Future directions in inflammatory bowel disease management.Optimizing Biologic Agents in Ulcerative Colitis and Crohn's Disease.Practical Use of Infliximab Concentration Monitoring in Pediatric Crohn Disease.Current and Future Status of Therapeutic Drug Monitoring in the Treatment of IBD.Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn's disease following ileocolonic resection.Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease.A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study.Rheumatology meets hepatology in 2012: a clinician's guideline for TNF inhibitors in hepatitis B/C virus carriers.Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development.Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease.Detection of adalimumab and antibodies to adalimumab using a homogeneous mobility shift assay.
P2860
Q34809305-0AB0EF2D-C0F4-4C68-87F8-FAB2B7DF3124Q37151351-266657D4-5989-415A-9C6E-63CD51FAB472Q38068963-457B9CFA-EEEE-4014-8229-17C496DF54F8Q38121115-99C827BF-FB0F-465A-B21D-A1532EA6F561Q38205305-4D521535-62C0-4A25-A66D-3F027FF94CF5Q38549995-16E6815C-4058-4749-B88A-7B4E30BAAB30Q38628770-6E04BFFA-821D-429F-8D96-96574A6E7D39Q39278646-41A3E00D-29A1-4366-B65A-AB3568EBC16AQ39542719-C7064FD9-85D9-4544-931C-C8A9055F6A9FQ41482221-11D25B17-B927-4BB2-B014-211AFC895A05Q44992977-5EDEDABE-D94B-45E3-AB00-FDC6E9BFA193Q45252016-B8061334-9775-44C7-911B-F1BF2633F951Q47221249-3D45077A-6105-4BFF-9502-54F97211F5A0Q50225754-17CA762A-50BF-4536-9A73-B54F994D77E5Q51158618-009BF476-FEF3-40EC-94B2-282E3C3B0C8E
P2860
Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anti-TNF trough levels and det ...... ady for everyday clinical use?
@en
Anti-TNF trough levels and det ...... ady for everyday clinical use?
@nl
type
label
Anti-TNF trough levels and det ...... ady for everyday clinical use?
@en
Anti-TNF trough levels and det ...... ady for everyday clinical use?
@nl
prefLabel
Anti-TNF trough levels and det ...... ady for everyday clinical use?
@en
Anti-TNF trough levels and det ...... ady for everyday clinical use?
@nl
P2093
P2860
P921
P1476
Anti-TNF trough levels and det ...... ady for everyday clinical use?
@en
P2093
Katalin Lorinczy
Lajos Sandor Kiss
Pal Miheller
P2860
P304
P356
10.1517/14712598.2012.644271
P407
P577
2011-12-12T00:00:00Z